• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过打破分子内氢键网络的对称性来提高铁螯合剂HBED的口服生物利用度。

Improving the oral bioavailability of the iron chelator HBED by breaking the symmetry of the intramolecular H-bond network.

作者信息

Faller B, Spanka C, Sergejew T, Tschinke V

机构信息

Research Department, Novartis Pharma AG, WKL-122.P.33, CH-4002 Basel, Switzerland.

出版信息

J Med Chem. 2000 Apr 20;43(8):1467-75. doi: 10.1021/jm990261n.

DOI:10.1021/jm990261n
PMID:10780902
Abstract

Physicochemical analysis and Monte Carlo simulations were used to identify structural features which prevent oral absorption of HBED, a potent iron chelator. In water the dominant conformations of HBED involve the hydrophobic collapse of the two aromatic rings. These conformations are favored in polar media because they expose the polar phenolic hydroxy groups to the solvent and partially shield the nonpolar aromatic rings. In a less polar solvent such as chloroform, a symmetrical H-bond network between the carboxylates and the amines dominates the conformational space. This leads to the exposure of the phenolic hydroxy groups to the solvent, which is unfavorable for solvation. The low solubility of HBED in nonpolar solvents was confirmed experimentally by determination of the partition coefficients in octanol, chloroform, and cyclohexane and may explain the poor membrane permeability of this compound. The high conformational stability which disfavors partitioning into phospholipids is mainly due to the symmetrical H-bond network. Potentiometric titrations of a monoester of HBED in MeOH/water indicate that the protonation sequence was changed compared to that of the parent compound, suggesting that the symmetrical H-bond network was disrupted. Conformational analysis in chloroform confirmed that, in contrast to HBED, no symmetric interaction between the carboxylate and the nitrogen amines is possible in the half-ester and a variety of conformations which allow partial shielding of the polar phenolic OH groups are energetically possible. This theoretical model predicting a better solubility of the half-esters in nonpolar solvents was supported by the large increase in the partition coefficients in octanol, chloroform, and cyclohexane measured experimentally. The high absorbability predicted by physicochemical and computer simulation methods was corroborated by in vivo experiments in marmoset monkeys where the monoethyl ester derivative of HBED was well-absorbed orally while the parent compound was nearly ineffective in the same model.

摘要

采用物理化学分析和蒙特卡罗模拟来确定阻碍强效铁螯合剂HBED口服吸收的结构特征。在水中,HBED的主要构象涉及两个芳香环的疏水塌缩。这些构象在极性介质中更受青睐,因为它们使极性酚羟基暴露于溶剂中,并部分屏蔽非极性芳香环。在极性较小的溶剂如氯仿中,羧酸盐和胺之间的对称氢键网络主导了构象空间。这导致酚羟基暴露于溶剂中,不利于溶剂化。通过测定HBED在辛醇、氯仿和环己烷中的分配系数,实验证实了其在非极性溶剂中的低溶解度,这可能解释了该化合物较差的膜通透性。不利于分配到磷脂中的高构象稳定性主要归因于对称氢键网络。HBED单酯在甲醇/水中的电位滴定表明,与母体化合物相比,质子化顺序发生了变化,这表明对称氢键网络被破坏。氯仿中的构象分析证实,与HBED不同,半酯中羧酸盐和氮胺之间不可能存在对称相互作用,并且存在多种构象,这些构象能使极性酚羟基部分被屏蔽,在能量上是可行的。通过实验测得的辛醇、氯仿和环己烷中分配系数的大幅增加,支持了该理论模型预测的半酯在非极性溶剂中具有更好的溶解度。物理化学和计算机模拟方法预测的高吸收性在狨猴体内实验中得到了证实,在该实验中,HBED的单乙酯衍生物口服吸收良好,而母体化合物在同一模型中几乎无效。

相似文献

1
Improving the oral bioavailability of the iron chelator HBED by breaking the symmetry of the intramolecular H-bond network.通过打破分子内氢键网络的对称性来提高铁螯合剂HBED的口服生物利用度。
J Med Chem. 2000 Apr 20;43(8):1467-75. doi: 10.1021/jm990261n.
2
Novel double prodrugs of the iron chelator N,N'-bis(2-hydroxybenzyl)ethylenediamine-N,N'-diacetic acid (HBED): Synthesis, characterization, and investigation of activation by chemical hydrolysis and oxidation.新型铁螯合剂 N,N'-双(2-羟基苄基)乙二胺-N,N'-二乙酸的双前药:合成、表征及化学水解和氧化激活的研究。
Eur J Med Chem. 2016 Aug 8;118:193-207. doi: 10.1016/j.ejmech.2016.04.037. Epub 2016 Apr 14.
3
A Double Prodrug with Improved Membrane Permeability over the Parent Chelator HBED Provides Superior Cytoprotection against Hydrogen Peroxide.一种双前药,与母体螯合剂HBED相比具有更高的膜通透性,对过氧化氢具有卓越的细胞保护作用。
ChemMedChem. 2016 Aug 5;11(15):1596-9. doi: 10.1002/cmdc.201600197. Epub 2016 Jul 21.
4
Caco-2 cell permeability of a new (hydroxybenzyl)ethylenediamine oral iron chelator: correlation with physicochemical properties and oral activity.一种新型(羟基苄基)乙二胺口服铁螯合剂的Caco-2细胞通透性:与理化性质及口服活性的相关性
J Pharm Sci. 1998 Sep;87(9):1041-5. doi: 10.1021/js980191s.
5
HBED: the continuing development of a potential alternative to deferoxamine for iron-chelating therapy.HBED:去铁胺用于铁螯合治疗的一种潜在替代药物的持续研发
Blood. 1999 Jan 1;93(1):370-5.
6
Chemical evaluation of HBED/Fe(3+) and the novel HJB/Fe(3+) chelates as fertilizers to alleviate iron chlorosis.HBED/Fe(3+) 和新型 HJB/Fe(3+) 配合物作为肥料缓解缺铁性贫血的化学评价。
J Agric Food Chem. 2009 Sep 23;57(18):8504-13. doi: 10.1021/jf9019147.
7
Fe-HBED Analogs: A Promising Class of Iron-Chelate Contrast Agents for Magnetic Resonance Imaging.Fe-HBED 类似物:磁共振成像用铁螯合物造影剂的一个有前途的类别。
Contrast Media Mol Imaging. 2019 Dec 20;2019:8356931. doi: 10.1155/2019/8356931. eCollection 2019.
8
Multifunctional antioxidant activity of HBED iron chelator.HBED铁螯合剂的多功能抗氧化活性
Free Radic Biol Med. 2001 Jan 15;30(2):170-7. doi: 10.1016/s0891-5849(00)00459-7.
9
Theoretical study of the gauche-trans equilibrium with and without an intramolecular hydrogen bond for +H3NCH2CH2X systems (X = OH, NH2, COO-) in solution.在溶液中对 +H3NCH2CH2X 体系(X = OH、NH2、COO-)进行有无分子内氢键的 gauche-trans 平衡的理论研究。
Phys Chem Chem Phys. 2012 Oct 28;14(40):13955-62. doi: 10.1039/c2cp42240a. Epub 2012 Sep 13.
10
Improvement of iron removal from the reticuloendothelial system by liposome encapsulation of N,N'-bis[2-hydroxybenzyl]-ethylenediamine-N,N'-diacetic acid (HBED). Comparison with desferrioxamine.通过脂质体包裹N,N'-双[2-羟基苄基]-乙二胺-N,N'-二乙酸(HBED)改善网状内皮系统的铁清除。与去铁胺的比较。
J Lab Clin Med. 1983 May;101(5):806-16.

引用本文的文献

1
Nanoparticle and iron chelators as a potential novel Alzheimer therapy.纳米颗粒和铁螯合剂作为一种潜在的新型阿尔茨海默病治疗方法。
Methods Mol Biol. 2010;610:123-44. doi: 10.1007/978-1-60327-029-8_8.
2
Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.铁的不良表现:不适当的铁螯合是血管及其他进行性炎症和退行性疾病病因的主要促成因素。
BMC Med Genomics. 2009 Jan 8;2:2. doi: 10.1186/1755-8794-2-2.
3
Novel diaroylhydrazine ligands as iron chelators: coordination chemistry and biological activity.
新型二芳酰肼配体作为铁螯合剂:配位化学与生物活性
J Biol Inorg Chem. 2005 Nov;10(7):761-77. doi: 10.1007/s00775-005-0018-0. Epub 2005 Nov 8.